Advertisement
Advertisement
LIVN
LivaNova PLC Ordinary Shares
76.22
USDSponsored
+0.44
+0.58%
Aug 07, 15:59 UTC -4
Closed
Pre-Market
76.22
0.00
0.00%
LIVN Earnings Reports
Positive Surprise Ratio
LIVN beat 35 of 42 last estimates.
83%
Next Report
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$388.45M
/$1.11
Implied change from Q2 26 (Revenue/ EPS)
-0.55%
/-11.90%
Implied change from Q3 25 (Revenue/ EPS)
+8.57%
/--
LivaNova PLC Ordinary Shares earnings per share and revenue
On Aug 05, 2026, LIVN reported earnings of 1.26 USD per share (EPS) for Q2 26, beating the estimate of 1.12 USD, resulting in a 12.32% surprise. Revenue reached 390.60 million, compared to an expected 388.37 million, with a 0.57% difference. The market reacted with a -8.41% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of 1.11 USD, with revenue projected to reach 388.45 million USD, implying an decrease of -11.90% EPS, and decrease of -0.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Teleflex Incorporated
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.29
Actual
$1.76
Surprise
+36.04%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.36
Actual
-$0.36
Surprise
+1.96%
GLOBUS MEDICAL INC
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.12
Actual
$1.34
Surprise
+19.50%
Artivion, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.01
Actual
$0.13
Surprise
+1,174.51%
Tandem Diabetes Care, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.31
Surprise
+4.94%
Delcath Systems Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
$0.07
Surprise
+176.25%
Treace Medical Concepts, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.24
Surprise
+21.05%
Inogen Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+10.88%
CVRx, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.53
Actual
-$0.53
Surprise
+0.90%
Hyperfine, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+1.96%
FAQ
What were LivaNova PLC Ordinary Shares's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, LivaNova PLC Ordinary Shares reported EPS of $1.26, beating estimates by 12.32%, and revenue of $390.60M, 0.57% above expectations.
How did the market react to LivaNova PLC Ordinary Shares's Q2 2026 earnings?
The stock price moved down -8.41%, changed from $85.33 before the earnings release to $78.14 the day after.
When is LivaNova PLC Ordinary Shares expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for LivaNova PLC Ordinary Shares's next earnings report?
Based on 10
analysts, LivaNova PLC Ordinary Shares is expected to report EPS of $1.11 and revenue of $388.45M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement